HIF-1α and cancer-associated fibroblasts (CAFs)-secreted TGF-β2 activate the expression GLI2 in CSCs, resulting in increased stemness/dedifferentiation and intrinsic resistance to chemotherapy. This evidence concerns the gene HIF1A and cancer.